||**Children With Diabetes UK**|**Children With Diabetes UK**|**Children With Diabetes UK**|**No (if any)**|
|---|---|---|---|---|
||**For the period**<br>**from**|12/07/2024|**To**|12/07/2025|
|**Section A Receipts and**|||||
|**payments**|**Unrestricted**<br>**funds**<br>**to the nearest      £**||||
||||||



## **A1 Receipts** 


**----- Start of picture text -----**<br>
                      3300<br>                           -<br>Sub total                        3300<br>A4  Asset  and  investment<br>purchases, (see table)<br>                           -<br>                           -<br>Sub total                            -<br>Total payments<br>Net of receipts/(payments)<br>A5 Transfers between funds A6  2700  Cash funds last<br>                      250<br>year end                             -<br>Donations                        3500  Cash funds this year end                             -<br>                           -<br>                           -  100<br>Endo<br>                           -<br>w<br>                           -  m Tot<br>Restricte en al<br>                           -  Last year<br>d funds t  fun<br>                           -  fu ds<br>nd<br>                           -  s<br>Sub total (Gross income for AR)                         3500  to the nearest  to the nearest  to the  to the nearest £<br>A2 Asset and investment sales, (see  £ £ near<br>est £<br>table).<br>                           -<br>                       -<br>                           -                         -<br>Sub total                             -                         -<br>                       -<br>Total receipts  A3 Payments                        -<br>Expenses                        3300                         -<br>                           -                         -<br>                       -<br>                           -<br>                       -<br>                           -<br>                           -<br>                           -<br>     -<br>                           -<br>                         -<br>                           -<br>**----- End of picture text -----**<br>





**----- Start of picture text -----**<br>
Unrestricted  Restricted funds  Endowment<br>funds  funds<br>to nearest £ to nearest £ to nearest £<br>**----- End of picture text -----**<br>



**----- Start of picture text -----**<br>
-  -                          3300<br>-<br>                           -                             -                           -<br>                           -                             -                           -<br>                           -                             -                           -<br>                         -                             -                           3300                         -<br>                         -<br>                         -                             -                             -                           -<br>                         -                             -                             -    -                        -    -                          3300                         -<br>                         -                             -                             -                           -<br>                         -                             -                             -                           -<br>                         -                           -                            100                         -<br>                         -                             -                             -                           -<br>                         -                           -                             -                           -<br>                         -                             -                             -                           -<br>                         -                           -                             -                           -<br>                         -                             -                             -                           -<br>                         -                             -                             -                           -                            -                             -                            100                         -<br>                         -                             -                           3300                        -<br>CCXX R1 accounts (SS)  1  29/01/2025<br>**----- End of picture text -----**<br>


## **Section B Statement of assets and liabilities at the end of the period** 

> **Categories B5 Liabilities** 

**B1 Cash funds** 


**----- Start of picture text -----**<br>
Details<br>Signed by one or two trustees on behalf of<br>all the trustees<br>CCXX R2 accounts (SS)<br> Details<br> Lloyds Account<br>**----- End of picture text -----**<br>


## **B2 Other monetary assets** 


**----- Start of picture text -----**<br>
 Details<br> Lloyds Account<br> Total cash funds<br>B3 Investment assets (agree balances with receipts and payments<br>account(s))<br>**----- End of picture text -----**<br>



**----- Start of picture text -----**<br>
Details<br>2<br>**----- End of picture text -----**<br>


**Details** 

**B4 Assets retained for the charity’s own use Details** 



**3500 - - - - - - - - 3500 - -** 

Agreement Error OK OK 

**Unrestricted funds** 

**to nearest £** 

**Restricted funds Endowment funds** 

**to nearest £ to nearest £** 

|**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**-**|**-**|
|---|---|---|
||**-**|**-**|
||**-**|**-**|
||**-**|**-**|
||**-**|**-**|
||**-**|**-**|



**Fund to which asset Cost (optional) Current value belongs (optional)** 

|**Fund to which asset**<br>**belongs**|**-**|**-**|
|---|---|---|
||**-**|**-**|
||**-**|**-**|
||**-**|**-**|
||**-**|**-**|
||**Cost (optional)**|**Current value**<br>**(optional)**|
||**-**|**-**|
||**-**|**-**|
||**-**|**-**|
||**-**|**-**|
||**-**|**-**|
||**-**|**-**|
||**-**|**-**|
||**-**|**-**|
||**-**|**-**|
||||



**Fund to which Amount due When due liability relates (optional) (optional)** Signature 

**-** 

Shehzad Mansha 



Print Name 

Date of approval 

26/11/2025 

29/01/2025 

